Engineering the Next Generation of Drugs
Swallowing pills means medication must face the challenge of surviving the harsh environment of the digestive tract. As a result, people must take larger doses than they need. Using micro and nano-fabrication techniques developed by the computer chip industry, Desai’s lab is creating tiny devices that take multiple drugs directly to where they are needed, using less medication, minimizing side effects and making the process safer for the patient.
Tejal Desai, PhD
Department of Bioengineering and Therapeutic Sciences
Funding for Desai’s research is provided by the Al Mann Foundation, Genentech, Juvenile Diabetes Research Foundation, Kimberly Clarke Corporation, National Institutes of Health, National Science Foundation, Rogers Family Foundation and Z-cube.